Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation.
Four monkeys were exposed to a total of 8 g each of manganese as oxide by repetitive subcutaneous injections during 5 months, after which they were left for 1 week to 6 months before they were sacrificed. All animals developed hyperactive behaviour after about 2 months. About 5 months after the start of the exposure the animals became hypoactive with an unsteady gait, and subsequently an action tremor appeared in some of the animals. The animals lost power in both upper and lower limbs and the movements of the hands and feet were very clumsy. The serum content of manganese rose 10-40 times during the exposure time and the content in brain was generally increased more than 10 times, with the highest content found in globus pallidus and putamen. The observed neurochemical effects were also largest in globus pallidus and putamen. In these regions there was a considerable depletion of dopamine and 3,4-dihydroxyphenylacetic acid, while the homovanillic acid content remained almost unchanged. A severe neuronal cell loss was observed in globus pallidus but not in other regions. This is in accordance with results from the most recent neuropathological study of a human suffering from chronic manganese poisoning [Yamada et al. (1986) Acta Neuropathol 70: 273-278] where globus pallidus was devoid of neuronal cells while the content of pigmented cells in substantia nigra was normal. Our data suggest a reduction in number of dopaminergic nerve terminals, as the activity of the dopamine synthesizing enzyme DOPA-decarboxylase was also lowered.(ABSTRACT TRUNCATED AT 250 WORDS)
Unit of Neurochemistry and Neurotoxicology, University of Stockholm, Sweden.
H
H
Eriksson
K
K
Mägiste
L O
LO
Plantin
F
F
Fonnum
K G
KG
Hedström
E
E
Theodorsson-Norheim
K
K
Kristensson
E
E
Stålberg
E
E
Heilbronn
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D004296:Dopa Decarboxylase / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D008252:Macaca fascicularis; D008297:Male; D008345:Manganese / Q000097:blood; D017895:Manganese Compounds; D020149:Manganese Poisoning; D009043:Motor Activity / Q000187:drug effects; D009420:Nervous System / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009496:Neurotensin / Q000378:metabolism; D010087:Oxides
D001679:Biogenic Amines; D017895:Manganese Compounds; D010087:Oxides; D009496:Neurotensin; D008345:Manganese; C027424:manganese oxide; D004296:Dopa Decarboxylase; D005978:Glutathione